Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy
Bowlus CL, Pockros PJ, Kremer A, Pares A, Forman LM, Drenth JPH, Ryder S, Terracciano L, Floreani A, Jin Y, Lieberman A, Pencek R, Iloeje U, Macconell L, Bedossa P (2019)
Publication Type: Conference contribution
Publication year: 2019
Journal
Publisher: ELSEVIER SCIENCE INC
City/Town: NEW YORK
Pages Range: E19-E19
Conference Proceedings Title: DIGESTIVE AND LIVER DISEASE
DOI: 10.1016/j.dld.2018.11.069
Authors with CRIS profile
Involved external institutions
University of California Davis (UCDAVIS)
United States (USA) (US)
Scripps Research Institute (TSRI)
United States (USA) (US)
Universitat de Barcelona (UB) / University of Barcelona
Spain (ES)
University of Colorado System
United States (USA) (US)
Radboud University Nijmegen Medical Centre / Radboudumc of voluit Radboud Universitair Medisch Centrum (UMC)
Netherlands (NL)
Nottingham University Hospitals
United Kingdom (GB)
Universität Basel
Switzerland (CH)
University of Padua / Universita degli Studi di Padova
Italy (IT)
Intercept Pharmaceuticals
United States (USA) (US)
University of Paris 7 - Denis Diderot / Université Paris VII Denis Diderot
France (FR)
United States (USA) (US)
Scripps Research Institute (TSRI)
United States (USA) (US)
Universitat de Barcelona (UB) / University of Barcelona
Spain (ES)
University of Colorado System
United States (USA) (US)
Radboud University Nijmegen Medical Centre / Radboudumc of voluit Radboud Universitair Medisch Centrum (UMC)
Netherlands (NL)
Nottingham University Hospitals
United Kingdom (GB)
Universität Basel
Switzerland (CH)
University of Padua / Universita degli Studi di Padova
Italy (IT)
Intercept Pharmaceuticals
United States (USA) (US)
University of Paris 7 - Denis Diderot / Université Paris VII Denis Diderot
France (FR)
How to cite
APA:
Bowlus, C.L., Pockros, P.J., Kremer, A., Pares, A., Forman, L.M., Drenth, J.P.H.,... Bedossa, P. (2019). Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy. In DIGESTIVE AND LIVER DISEASE (pp. E19-E19). NEW YORK: ELSEVIER SCIENCE INC.
MLA:
Bowlus, C. L., et al. "Three years of obeticholic Acid (OCA) therapy results in histological improvements in patients with primary biliary cholangitis: further analysis of the POISE Biopsy substudy." Proceedings of the DIGESTIVE AND LIVER DISEASE NEW YORK: ELSEVIER SCIENCE INC, 2019. E19-E19.
BibTeX: Download